Dynamical Neurofeedback has been the subject of a scientific study published on the treatment of the Disorder Attention-Deficit and Hyperactivity disorder (ADHD) at the Laboratory of Neuroscience and Functional Pathologies of the CHU of Amiens (UMR 8160, a unit of the CNRS). This study compares the effects of neurofeedback carried out with the software NeuroCARE® (today renamed NeurOptimal™) and those of Ritalin on children with this disorder.
"Dynamical Neurofeedback meets the criteria of the american Academy of Psychiatry of children and adolescents as a clinical recommendation for the treatment of the disorder attention-deficit and hyperactivity disorder (add/ADHD), epilepsy, anxiety, Obsessive Compulsive Disorders (OCD,) Syndrome of Post-Traumatic Stress disorder, phobias, depression, difficulty reading, and addiction to alcohol or drugs. This suggests that Dynamical Neurofeedback should always be considered by clinicians as a method of intervention for these disorders ".
To this day, the Dynamical Neurofeedback is practiced in France, in Canada, the united States, with thousands of sessions per day. As well as several hospitals use Dynamical Neurofeedback. Such quel hôpital de la Pitié-Salpêtrière hospital in Paris for sleep disorders and autism (Department of clinical Neurophysiology and Department of Psychiatry, Child and Adolescent, the Pole of the diseases of the nervous system, respectively) and for disorders of Alzheimer's disease (Institute of Memory and Alzheimer's Disease and Institute of Brain and spinal Cord). The hôpital Sainte-Marguerite Marseille also uses recently neurofeedback for the treatment of epilepsy.
Thousands of sessions have been carried out by practitioners for the past 12 years in the world, showing thatthe Dynamical Neurofeedback, is 100% secure and non-invasive.
Users testify